Stanford researchers develop stroke treatment that changes the game that doubles effectiveness

Stanford University researchers say they have developed a more effective way to treat cerebrovascular accidents.

It has been shown that the new technology, called Milli-SPinner’s thrombus, has more successful results for patients who have experienced cerebrovascular accidents, as well as heart attacks, pulmonary cushioning and other clothe’s diseases, according to a university statement.

Blood clots are joined by thread -like proteins called fibrin. Milli-spinner, which is a long, empty and rotating tube with a series of “fins and slits”, enters the body through a catheter and applies strength and suction to the clot.

Experimental cholesterol pill cuts the risk of heart attack with dose once a day

As a result, the blood clot is reduced in size, up to 5% of its original volume, without breaking any of the fibrine threads.

This is important because breaking the clot can lead to pieces that escape and are stuck to difficult access places, researchers pointed.

With Milli-SPINNER, red blood cells are “released” and much smaller fibrin clot is removed from the body.

“With existing technology, there is no way to reduce the size of the clot. They are based on deforming and breaking the clot to eliminate it,” said Senior Author Renee Zhao, Deputy Professor of Mechanical Engineering, in the statement.

Boy, 6, suffers from a stroke that can jeopardize the life that causes paralysis: “rare complication”

“What is unique from Milli-SPinner is that it applies compression and shear forces to reduce the entire clot, dramatically reducing volume without causing rupture.”

Time is essential when it comes to an ischemic stroke, which is when the clot is cutting oxygen in the brain. Studies have shown that for each minute during a stroke, 1.9 million brain neurons and 14 billion synapses are destroyed.

With current technologies, clothes are only eliminated by about half the time in the first test, said the launch and completely fails 15% of the time.

“In most cases, we are more than duplicated the effectiveness of current technology and for the most difficult clots, which we eliminate only 11% of the time with current devices, we are open the artery at the first attempt of 90% of the time,” said co -author Jeremy Heit, head of neuroimage and Stanford neuroinent, in launch.

Click here to get the Fox News app

“This is a sea change technology that will drastically improve our ability to help people.”

The findings of the researchers, who incorporated both animal and flow -based flow models studies, were published on June 4 in the journal Nature.

Click here to register -you are in our health newsletter

Multispinner could be used for other applications, such as capturing and removing renal stone fragments, said the launch.

The team is now working to get the new technology to be approved for clinical use, and clinical trials are expected to begin soon.

“What makes this technology really exciting is its unique mechanism for actively remodeling compact clots, instead of extracting them,” Zhao said.

“We are working to bring this in clinical environments, where the success rate of thrombusal procedures could significantly increase and save patients’ lives.”

For more health items, visit www.foxnews.com/health

Fox News Digital contacted researchers and cardiologists for comments.